Vernal Biosciences, Inc. — Form D
Vernal Biosciences, Inc. of Colchester, VT, a company, filed a Form D exempt-offering notice with the SEC on 2022-05-25. The offering totals $21.0M, of which $21.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-05-25
- Form: D
- Accession: 0001861147-22-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $21.0M
- Amount sold: $21.0M
- Investors: 10
- Date of first sale: 2022-05-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-446902
Issuer
- Name: Vernal Biosciences, Inc.
- CIK: 0001861147
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 261 Mountain View Drive, Colchester, VT, 05461
- Phone: 512-791-9680
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Errik Anderson | Director | Cambridge, MA |
| Gustavo Mahler | Director | Colchester, VT |
| Daniella Kranjac | Director | New York, NY |
| David Anderson | Director | Calgary, A0 |
| Christian Cobaugh | Director | Colchester, VT |
| Christian Cobaugh | Executive Officer | Colchester, VT |
Other filings by this issuer (2)
More